SLC30A3 and Alzheimer disease: ZnT3 has been identified as critical for transport of zinc into synaptic vesicles of a subset of glutamatergic neurons [63–65], and ZnT3 expression is reduced in patients with Alzheimer’s disease [66, 67] and Parkinson’s disease-related dementia [68].